Long non-coding RNAs in lung cancer: Unraveling the molecular modulators of MAPK signaling

MS Hussain, O Afzal, G Kumar, ASA Altamimi… - … -Research and Practice, 2023 - Elsevier
Lung cancer (LC) continues to pose a significant global medical burden, necessitating a
comprehensive understanding of its molecular foundations to establish effective treatment …

Non-Coding RNAs as key regulators in lung cancer

I Gilyazova, G Gimalova, A Nizamova… - International journal of …, 2023 - mdpi.com
For several decades, most lung cancer investigations have focused on the search for
mutations in candidate genes; however, in the last decade, due to the fact that most of the …

LncRNA SPRY4-IT1 regulates 16HBE cell malignant transformation induced by particulate matter through DUSP6-ERK1/2-Chk1 signaling pathway

Y Li, D Tang, J Zhang, W Ou, X Sun, Q Yang, J Wu - Chemosphere, 2023 - Elsevier
Particulate matter (PM), one of the most serious air contaminants, could easily pass through
the airway and deposit at the deep alveoli. Thus, it might trigger respiratory diseases like …

Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer

M Gao, Y Li, P Cao, H Liu, J Chen, S Kang - Frontiers in Oncology, 2023 - frontiersin.org
The pathogenesis of lung cancer (LC) is a multifaceted process that is influenced by a
variety of factors. Alongside genetic mutations and environmental influences, there is …

[HTML][HTML] The pharmacological and biological importance of EZH2 signaling in lung cancer

M Entezari, A Taheriazam, MDA Paskeh… - Biomedicine & …, 2023 - Elsevier
Up to 18% of cancer-related deaths worldwide are attributed to lung tumor and global
burden of this type of cancer is ascending. Different factors are responsible for development …

PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathway

Y Zhang, H Chen, R Yuan, Y Wang… - Molecular …, 2023 - Wiley Online Library
Abstract Pyruvate dehydrogenase kinase 1 (PDK1) is a widely known glycolytic enzyme,
and some evidence showed that PDK1 promoted breast cancer by multiple approaches …

Epithelial to Mesenchymal Transition in Lung Cancer: When It Starts?

R Pirlog, P Chiroi, L Raduly, A Nutu, A Cismaru… - 2023 - Springer
Epithelial to mesenchymal transition (EMT) represents a phenotypic change that occurs in
epithelial tumors that is required for cancer cells to acquire metastatic potential. This …